Tci Wealth Advisors, Inc. Mannkind Corp Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$3.95 - $5.63 $2,915 - $4,154	738 New	738 $3,000
Q1 2022 Apr 29, 2022	SELL	$2.62 - $4.45 $2,889 - $4,908	-1,103 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$4.05 - $5.37 $1,931 - $2,561	477 Added 76.2%	1,103 $5,000
Q2 2021 Aug 02, 2021	BUY	$3.61 - $5.45 $483 - $730	134 Added 27.24%	626 $3,000
Q1 2021 Apr 29, 2021	BUY	$3.14 - $6.14 $1,544 - $3,020	492 New	492 $2,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.75B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.